White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium.

There is a growing interest in realizing the benefits of continuous processing in biologics manufacturing, which is reflected by the significant number of industrial and academic researchers who are actively involved in the development of continuous bioprocessing systems. These efforts are further encouraged by guidance expressed in recent US FDA conference presentations. The advantages of continuous manufacturing include sustained operation with consistent product quality, reduced equipment size, high-volumetric productivity, streamlined process flow, low-process cycle times, and reduced capital and operating cost. This technology, however, poses challenges, which need to be addressed before routine implementation is considered. This paper, which is based on the available literature and input from a large number of reviewers, is intended to provide a consensus of the opportunities, technical needs, and strategic directions for continuous bioprocessing. The discussion is supported by several examples illustrating various architectures of continuous bioprocessing systems.

[1]  Alex Xenopoulos,et al.  A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies. , 2015, Journal of biotechnology.

[2]  S. G. Desai.  Continuous and semi-continuous cell culture for production of blood clotting factors. , 2015, Journal of biotechnology.

[3]  Alois Jungbauer,et al.  Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation. , 2014, Biotechnology journal.

[4]  Véronique Chotteau,et al.  Very High Density of Chinese Hamster Ovary Cells in Perfusion by Alternating Tangential Flow or Tangential Flow Filtration in WAVE Bioreactor™—Part II: Applications for Antibody Production and Cryopreservation , 2013, Biotechnology progress.

[5]  Daniel G Bracewell,et al.  Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture. , 2013, Journal of chromatography. A.

[6]  Andrew L. Zydney,et al.  Continuous Countercurrent Tangential Chromatography for Monoclonal Antibody Purification , 2013 .

[7]  Suzanne S Farid,et al.  Fed‐batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty , 2013, Biotechnology and bioengineering.

[8]  Daniel Cummings,et al.  Integrated continuous production of recombinant therapeutic proteins , 2012, Biotechnology and bioengineering.

[9]  Volker Hessel,et al.  Process intensification–engineering for efficiency, sustainability and flexibility , 2012 .

[10]  Marcella Yu,et al.  Effects of cell culture conditions on antibody N‐linked glycosylation—what affects high mannose 5 glycoform , 2011, Biotechnology and bioengineering.

[11]  H Baldascini,et al.  Rapid whole monoclonal antibody analysis by mass spectrometry: An Ultra scale‐down study of the effect of harvesting by centrifugation on the post‐translational modification profile , 2010, Biotechnology and bioengineering.

[12]  David Reay,et al.  Process Intensification: Engineering for Efficiency, Sustainability and Flexibility , 2008 .

[13]  Trevor Laird.  Continuous Processes in Small-Scale Manufacture , 2007 .

[14]  Konstantin Konstantinov,et al.  Continuous annular chromatography: General characterization and application for the isolation of recombinant protein drugs. , 2002, Biotechnology and bioengineering.

[15]  N. Anderson.  Practical Use of Continuous Processing in Developing and Scaling Up Laboratory Processes , 2001 .

[16]  A. Heinrich. Tanner.  Continuous casting : a revolution in steel : the worldwide success story of Concast AG, Zurich , 1998 .

[17]  Clayton M. Christensen.  The Innovator's Dilemma , 1997 .

[18]  James M. Utterback,et al.  Mastering the Dynamics of Innovation , 1996 .

[19]  D K Robinson,et al.  Characterization of a recombinant antibody produced in the course of a high yield fed‐batch process , 1994, Biotechnology and bioengineering.